Rehabilitation After Radiotherapy for Prostate Cancer
Launched by ODENSE UNIVERSITY HOSPITAL · Jan 7, 2011
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
More cancer patients are now being cured or living a long time with the disease. Prostate cancer (PCa) is one of the cancer diseases, where the treatment can give some late side effects and cause reduced life quality.
This project will as a part of a ph.d. study, test and evaluate a rehabilitation programme, which will empower the mens health and give them resources to face at new everyday life.
The project is consisted of a randomised controlled test of the intervention and qualitative evaluation.
More and more Danish men are diagnosed with PC, the incidence increased with 34 percent fr...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with localized og locally advanced prostate cancer treated with curative intended radiotherapy at Department of Oncology Odense University Hospital in the period of inclusion
- Exclusion Criteria:
- • Patients younger than 18
- • Patients who cannot understand/read or speak danish
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Trial Officials
Olfred Hansen, Dr. med Phd
Principal Investigator
Department of Oncology Odense University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials